The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

The EACR’s Top 10 Cancer Research Publications: November 2019

October 17, 2025
EACR top 10 cancer research publications

The EACR’s Top 10 Cancer Research Publications is a regular summary of the most interesting and impactful recent papers in cancer research. It is curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

  • 1. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
  • 2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
  • 3. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
  • 4. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
  • 5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging
  • 6. Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
  • 7. Quantitative evidence for early metastatic seeding in colorectal cancer
  • 8. Metabolic landscape of the tumor microenvironment at single cell resolution
  • 9. Flower isoforms promote competitive growth in cancer
  • 10. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Previous
Next

C. Yan et al., Cell 177, 1903–1914 June 13, 2019

Immunodeficient Zebrafish: The EACR’s Top 10 Cancer Research PublicationsSummary of the findings

Xenograft cell transplantation into immunodeficient mice has become the gold standard for assessing pre-clinical efficacy of cancer drugs, yet direct visualization of single-cell phenotypes is difficult. Here, we report an optically-clear prkdc−/−, il2rga−/− zebrafish that lacks adaptive and natural killer immune cells, can engraft a wide array of human cancers at 37°C, and permits the dynamic visualization of single engrafted cells. For example, photoconversion cell-lineage tracing identified migratory and proliferative cell states in human rhabdomyosarcoma, a pediatric cancer of muscle. Additional experiments identified the preclinical efficacy of combination olaparib PARP inhibitor and temozolomide DNA-damaging agent as an effective therapy for rhabdomyosarcoma and visualized therapeutic responses using a four-color FUCCI cell-cycle fluorescent reporter. These experiments identified that combination treatment arrested rhabdomyosarcoma cells in the G2 cell cycle prior to induction of apoptosis. Finally, patient-derived xenografts could be engrafted into our model, opening new avenues for developing personalized therapeutic approaches in the future.

Read more in Cell

2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

  • 1. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
  • 2. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
  • 3. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
  • 4. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
  • 5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging
  • 6. Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
  • 7. Quantitative evidence for early metastatic seeding in colorectal cancer
  • 8. Metabolic landscape of the tumor microenvironment at single cell resolution
  • 9. Flower isoforms promote competitive growth in cancer
  • 10. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Previous
Next
Tags: EACR BoardEACR Top Ten Cancer Research Publicationspublication

Related Posts

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk...

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026

Nazha Ghaleb (who goes by Nana) has been an EACR member for over two years, and an EACR Ambassador for much of that time. A molecular...

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference
Community

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community
Community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR